Biopharmaceutical CMO And CRO Market Size, Share & Trends Analysis Report By Source (Mammalian, Non-mammalian), By Service (Contract Manufacturing, Contract Research), By Product, And Segment Forecasts, 2023 - 2030

Table of content

Chapter 1 Research Methodology
                   1.1 Market Segmentation & Scope
                   1.2 Market Definition
                   1.3 Information Procurement
                       1.3.1 Purchased database
                       1.3.2 GVR’s internal database
                       1.3.3 Secondary sources & third party perspectives
                       1.3.4 Primary research
                   1.4 Information Analysis
                       1.4.1 Data analysis models
                   1.5 Market Formulation & Data Visualization
                   1.6 Data Validation & Publishing
Chapter 2 Executive Summary
                   2.1 Biopharmaceutical CMO & CRO Market Outlook, 2018-2030
Chapter 3 Industry Outlook: Market Variables, Trends, & Scope
                   3.1 Market Liniage
                       3.1.1 Parent Market
                       3.1.2 Ancialiary Market
                   3.2 Biopharmaceutical CMO & CRO Market: Market Dynamics
                       3.2.1 Market driver analysis
                           3.2.1.1 Rising investment by CMOs for capacity expansion
                           3.2.1.2 Commercial success of biopharmaceuticals and consequent increased demand for the biopharmaceuticals
                           3.2.1.3 Robust biopharmaceuticals pipeline
                           3.2.1.4 Cost and time saving benefits offered by contract services
                       3.2.2 Market restraint analysis
                           3.2.2.1 Limited outsourcing amongst well-stablished biopharmaceutical manufacturer
                   3.4 Key Opportunity Analysis
                       3.4.1 Rising funds in biopharmaceutical indutry
                       3.4.2 Mergers & acquistion for facility expansion
                       3.4.3 Growing demand for protein therapeutics
                   3.5 Industry Analysis – Porter’s
                       3.5.1 Supplier Power: Substantial number of suppliers for bioprocessing equipment contributes to the low supplier power
                       3.5.2 Buyer Power: Fragmented nature of biopharmaceutical industry has led to moderate bargaining power of buyers
                       3.5.3 Substitution Threat: High due to presence of several big pharma companies
                       3.5.4 New Entrants Threat: Presence of established players coupled with need of adequate capacity results in moderate threat of new entrants
                       3.5.5 Competitive Rivalry: High due to fragmented nature of market
                   3.6 Biopharmaceuticals CMO & CRO PEST Analysis
                       3.6.1 Political landscape
                       3.6.2 Economic landscape
                       3.6.3 Social landscape
                       3.6.4 Technology landscape
                   3.7 COVID-19 Impact and Reformation Analysis
Chapter 4 Biopharmaceuticals CMO & CRO Market: Source Estimates & Trend Analysis
                   4.1 Biopharmaceuticals CMO & CRO Market: Source Movement Analysis
                   4.2 Mammalian Source
                       4.2.1 Mammalian source market, 2018-2030 (USD Million)
                   4.3 Non-mammalian Source
                       4.3.1 Non-mammalian source market, 2018-2030 (USD Million)
Chapter 5 Biopharmaceuticals CMO & CRO Market: Service Type Estimates & Trend Analysis
                   5.1 Biopharmaceuticals CMO & CRO Market: Service Type Movement Analysis
                   5.2 Contract Manufacturing, by service
                       5.2.1 Contract manufacturing market, 2018-2030 (USD Million)
                       5.2.2 Process development
                           5.2.2.1 Process development market, 2018-2030 (USD Million)
                           5.2.2.2 Downstream processing
                               5.2.2.2.1 Downstream processing market, 2018-2030 (USD Million)
                           5.2.2.3 Upstream processing
                               5.2.2.3.1 Upstream processing market, 2018-2030 (USD Million)
                       5.2.3 Fill & finish operations
                           5.2.3.1 Fill & finish operations market, 2018-2030 (USD Million)
                       5.2.4 Analytical & QC testing
                           5.2.4.1 Analytical & QC testing market, 2018-2030 (USD Million)
                       5.2.5 Packaging
                           5.2.5.1 Contract packaging market, 2018-2030 (USD Million)
                   5.3 Contract Research
                       5.3.1 Contract research market, 2018-2030 (USD Million)
                       5.3.2 Oncology
                           5.3.2.1 Oncology market, 2018-2030 (USD Million)
                       5.3.3 Inflammation & immunology
                           5.3.3.1 Inflammation & immunology market, 2018-2030 (USD Million)
                       5.3.4 Cardiology
                           5.3.4.1 Cardiology market, 2018-2030 (USD Million)
                       5.3.5 Neuroscience
                           5.3.5.1 Neuroscience market, 2018-2030 (USD Million)
                       5.3.6 Others
                           5.3.6.1 Other CRO services market, 2018-2030 (USD Million)
Chapter 6 Biopharmaceuticals CMO & CRO Market: Product Estimates & Trend Analysis
                   6.1 Biopharmaceuticals CMO & CRO Market: Product Movement Analysis
                   6.2 Biologics
                       6.2.1 Biologics market, 2018-2030 (USD Million)
                       6.2.2 Monoclonal Antibodies
                           6.2.2.1 Monoclonal antibodies market, 2018-2030 (USD Million)
                       6.2.3 Recombinant proteins
                           6.2.3.1 Recombinant proteins market, 2018-2030 (USD Million)
                       6.2.4 Vaccines
                           6.2.4.1 Vaccines market, 2018-2030 (USD Million)
                       6.2.5 Antisense, RNAi, & molecular therapy
                           6.2.5.1 Antisense, RNAi, &molecular therapy market, 2018-2030 (USD Million)
                       6.2.6 Others
                           6.2.6.1 Other product market, 2018-2030 (USD Million)
                   6.3 Biosimilars
                       6.3.1 Biosimilars market, 2018-2030 (USD Million)
Chapter 7 Biopharmaceuticals CMO & CRO Market: Regional Estimates & Trend Analysis, by Service, Source, & Product
                   7.1 Biopharmaceuticals CMO & CRO Market Share By Region, 2021 & 2030
                   7.2 North America
                       7.2.1 North America Biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Million)
                       7.2.2 U.S.
                           7.2.2.1 U.S. biopharmaceuticals CMO & CRO market, by source, 2018 - 2030 (USD Million)
                           7.2.2.2 U.S. biopharmaceuticals CMO & CRO market, by service, 2018 - 2030 (USD Million)
                           7.2.2.3 U.S. biopharmaceuticals CMO & CRO market, by products, 2018 - 2030 (USD Million)
                       7.2.3 Canada
                           7.2.3.1 Canada biopharmaceuticals CMO & CRO market, by source, 2018 - 2030 (USD Million)
                           7.2.3.2 Canada biopharmaceuticals CMO & CRO market, by service, 2018 - 2030 (USD Million)
                           7.2.3.3 Canada biopharmaceuticals CMO & CRO market, by products, 2018 - 2030 (USD Million)
                   7.3 Europe
                       7.3.1 Europe Biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Million)
                       7.3.2 UK
                           7.3.2.1 UK biopharmaceuticals CMO & CRO market, by source, 2018 - 2030 (USD Million)
                           7.3.2.2 UK biopharmaceuticals CMO & CRO market, by service, 2018 - 2030 (USD Million)
                           7.3.2.3 UK biopharmaceuticals CMO & CRO market, by products, 2018 - 2030 (USD Million)
                       7.3.3 Germany
                           7.3.3.1 Germany biopharmaceuticals CMO & CRO market, by source, 2018 - 2030 (USD Million)
                           7.3.3.2 Germany biopharmaceuticals CMO & CRO market, by service, 2018 - 2030 (USD Million)
                           7.3.3.3 Germany biopharmaceuticals CMO & CRO market, by products, 2018 - 2030 (USD Million)
                       7.3.4 France
                           7.3.4.1 France biopharmaceuticals CMO & CRO market, by source, 2018 - 2030 (USD Million)
                           7.3.4.2 France biopharmaceuticals CMO & CRO market, by service, 2018 - 2030 (USD Million)
                           7.3.4.3 France biopharmaceuticals CMO & CRO market, by products, 2018 - 2030 (USD Million)
                       7.3.5 Italy
                           7.3.5.1 Italy biopharmaceuticals CMO & CRO market, by source, 2018 - 2030 (USD Million)
                           7.3.5.2 Italy biopharmaceuticals CMO & CRO market, by service, 2018 - 2030 (USD Million)
                           7.3.5.3 Italy biopharmaceuticals CMO & CRO market, by products, 2018 - 2030 (USD Million)
                       7.3.6 Spain
                           7.3.6.1 Spain biopharmaceuticals CMO & CRO market, by source, 2018 - 2030 (USD Million)
                           7.3.6.2 Spain biopharmaceuticals CMO & CRO market, by service, 2018 - 2030 (USD Million)
                           7.3.6.3 Spain biopharmaceuticals CMO & CRO market, by products, 2018 - 2030 (USD Million)
                       7.3.7 Norway
                           7.3.7.1 Norway biopharmaceuticals CMO & CRO market, by source, 2018 - 2030 (USD Million)
                           7.3.7.2 Norway biopharmaceuticals CMO & CRO market, by service, 2018 - 2030 (USD Million)
                           7.3.7.3 Norway biopharmaceuticals CMO & CRO market, by products, 2018 - 2030 (USD Million)
                       7.3.8 Sweden
                           7.3.8.1 Sweden biopharmaceuticals CMO & CRO market, by source, 2018 - 2030 (USD Million)
                           7.3.8.2 Sweden biopharmaceuticals CMO & CRO market, by service, 2018 - 2030 (USD Million)
                           7.3.8.3 Sweden biopharmaceuticals CMO & CRO market, by products, 2018 - 2030 (USD Million)
                       7.3.9 Denmark
                           7.3.9.1 Denmark biopharmaceuticals CMO & CRO market, by source, 2018 - 2030 (USD Million)
                           7.3.9.2 Denmark biopharmaceuticals CMO & CRO market, by service, 2018 - 2030 (USD Million)
                           7.3.9.3 Denmark biopharmaceuticals CMO & CRO market, by products, 2018 - 2030 (USD Million)
                   7.4 Asia Pacific
                       7.4.1 Asia Pacific biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Million)
                       7.4.2 China
                           7.4.2.1 China biopharmaceuticals CMO & CRO market, by source, 2018 - 2030 (USD Million)
                           7.4.2.2 China biopharmaceuticals CMO & CRO market, by service, 2018 - 2030 (USD Million)
                           7.4.2.3 China biopharmaceuticals CMO & CRO market, by products, 2018 - 2030 (USD Million)
                       7.4.3 India
                           7.4.3.1 India biopharmaceuticals CMO & CRO market, by source, 2018 - 2030 (USD Million)
                           7.4.3.2 India biopharmaceuticals CMO & CRO market, by service, 2018 - 2030 (USD Million)
                           7.4.3.3 India biopharmaceuticals CMO & CRO market, by products, 2018-2030 (USD Million)
                       7.4.4 Japan
                           7.4.4.1 Japan biopharmaceuticals CMO & CRO market, by source, 2018-2030 (USD Million)
                           7.4.4.2 Japan biopharmaceuticals CMO & CRO market, by service, 2018-2030 (USD Million)
                           7.4.4.3 Japan biopharmaceuticals CMO & CRO market, by products, 2018-2030 (USD Million)
                       7.4.5 Australia
                           7.4.5.1 Australia biopharmaceuticals CMO & CRO market, by source, 2018-2030 (USD Million)
                           7.4.5.2 Australia biopharmaceuticals CMO & CRO market, by service, 2018-2030 (USD Million)
                           7.4.5.3 Australia biopharmaceuticals CMO & CRO market, by products, 2018-2030 (USD Million)
                       7.4.6 South Korea
                           7.4.6.1 South Korea biopharmaceuticals CMO & CRO market, by source, 2018-2030 (USD Million)
                           7.4.6.2 South Korea biopharmaceuticals CMO & CRO market, by service, 2018-2030 (USD Million)
                           7.4.6.3 South Korea biopharmaceuticals CMO & CRO market, by products, 2018-2030 (USD Million)
                       7.4.7 Thailand
                           7.4.7.1 Thailand biopharmaceuticals CMO & CRO market, by source, 2018-2030 (USD Million)
                           7.4.7.2 Thailand biopharmaceuticals CMO & CRO market, by service, 2018-2030 (USD Million)
                           7.4.7.3 Thailand biopharmaceuticals CMO & CRO market, by products, 2018-2030 (USD Million)
                   7.5 Latin America
                       7.5.1 Latin America biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Million)
                       7.5.2 Brazil
                           7.5.2.1 Brazil biopharmaceuticals CMO & CRO market, by source, 2018 - 2030 (USD Million)
                           7.5.2.2 Brazil biopharmaceuticals CMO & CRO market, by service, 2018 - 2030 (USD Million)
                           7.5.2.3 Brazil biopharmaceuticals CMO & CRO market, by products, 2018-2030 (USD Million)
                       7.5.3 Mexico
                           7.5.3.1 Mexico biopharmaceuticals CMO & CRO market, by source, 2018-2030 (USD Million)
                           7.5.3.2 Mexico biopharmaceuticals CMO & CRO market, by service, 2018-2030 (USD Million)
                           7.5.3.3 Mexico biopharmaceuticals CMO & CRO market, by products, 2018-2030 (USD Million)
                       7.5.4 Colombia
                           7.5.4.1 Colombia biopharmaceuticals CMO & CRO market, by source, 2018-2030 (USD Million)
                           7.5.4.2 Colombia biopharmaceuticals CMO & CRO market, by service, 2018-2030 (USD Million)
                           7.5.4.3 Colombia biopharmaceuticals CMO & CRO market, by products, 2018-2030 (USD Million)
                       7.5.5 Argentina
                           7.5.5.1 Argentina biopharmaceuticals CMO & CRO market, by source, 2018-2030 (USD Million)
                           7.5.5.2 Argentina biopharmaceuticals CMO & CRO market, by service, 2018-2030 (USD Million)
                           7.5.5.3 Argentina biopharmaceuticals CMO & CRO market, by products, 2018-2030 (USD Million)
                   7.6 Middle East & Africa (MEA)
                       7.6.1 Middle East & Africa biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Million)
                       7.6.2 South Africa
                           7.6.2.1 South Africa biopharmaceuticals CMO & CRO market, by source, 2018 - 2030 (USD Million)
                           7.6.2.2 South Africa biopharmaceuticals CMO & CRO market, by service, 2018 - 2030 (USD Million)
                           7.6.2.3 South Africa biopharmaceuticals CMO & CRO market, by products, 2018-2030 (USD Million)
                       7.6.3 Saudi Arabia
                           7.6.3.1 Saudi Arabia biopharmaceuticals CMO & CRO market, by source, 2018-2030 (USD Million)
                           7.6.3.2 Saudi Arabia biopharmaceuticals CMO & CRO market, by service, 2018-2030 (USD Million)
                           7.6.3.3 Saudi Arabia biopharmaceuticals CMO & CRO market, by products, 2018-2030 (USD Million)
                       7.6.4 UAE
                           7.6.4.1 UAE biopharmaceuticals CMO & CRO market, by source, 2018-2030 (USD Million)
                           7.6.4.2 UAE biopharmaceuticals CMO & CRO market, by service, 2018-2030 (USD Million)
                           7.6.4.3 UAE biopharmaceuticals CMO & CRO market, by products, 2018-2030 (USD Million)
                       7.6.5 Kuwait
                           7.6.5.1 Kuwait biopharmaceuticals CMO & CRO market, by source, 2018-2030 (USD Million)
                           7.6.5.2 Kuwait biopharmaceuticals CMO & CRO market, by service, 2018-2030 (USD Million)
                           7.6.5.3 Kuwait biopharmaceuticals CMO & CRO market, by products, 2018-2030 (USD Million)
Chapter 8 Competitive Landscape
                   8.1 Company Profiles
                       8.1.1 Boehringer Ingelheim GmbH
                           8.1.1.1 Company overview
                           8.1.1.2 Financial performance
                           8.1.1.3 Product benchmarking
                           8.1.1.4 Strategic initiatives
                       8.1.2 LONZA
                           8.1.2.1 Company overview
                           8.1.2.2 Financial performance
                           8.1.2.3 Product benchmarking
                           8.1.2.4 Strategic initiatives
                       8.1.3 Inno Biologics Sdn Bhd
                           8.1.3.1 Company overview
                           8.1.3.2 Financial performance
                           8.1.3.3 Product benchmarking
                           8.1.3.4 Strategic initiatives
                       8.1.4 Rentschler Biotechnologie GmbH
                           8.1.4.1 Company overview
                           8.1.4.2 Financial performance
                           8.1.4.3 Product benchmarking
                           8.1.4.4 Strategic initiatives
                       8.1.5 JRS PHARMA
                           8.1.5.1 Company overview
                               8.1.5.1.1 CELONIC AG
                           8.1.5.2 Financial performance
                               8.1.5.2.1 Financial performance
                           8.1.5.3 Product benchmarking
                           8.1.5.4 Strategic initiatives
                       8.1.6 BIOMEVA GmbH
                           8.1.6.1 Company overview
                           8.1.6.2 Financial performance
                           8.1.6.3 Product benchmarking
                           8.1.6.4 Strategic initiatives
                       8.1.7 ProBioGen
                           8.1.7.1 Company overview
                           8.1.7.2 Financial performance
                           8.1.7.3 Product benchmarking
                           8.1.7.4 Strategic initiatives
                       8.1.8 FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
                           8.1.8.1 Company overview
                           8.1.8.2 Financial performance
                           8.1.8.3 Product benchmarking
                           8.1.8.4 Strategic initiatives
                       8.1.9 TOYOBO CO., LTD.
                           8.1.9.1 Company overview
                           8.1.9.2 Financial performance
                           8.1.9.3 Product benchmarking
                           8.1.9.4 Strategic initiatives
                           8.1.10.4 Strategic initiatives
                       8.1.10 Thermo Fisher Scientific Inc
                           8.1.10.1 Company overview
                               8.1.10.1.1 DPx
                           8.1.10.2 Financial performance
                           8.1.10.3 Product benchmarking
                           8.1.10.4 Strategic initiatives
                       8.1.11 CMC Biologics
                           8.1.11.1 Company overview
                           8.1.11.2 Financial performance
                           8.1.11.3 Product benchmarking
                           8.1.11.4 Strategic initiatives
                       8.1.12 Binex Co., Ltd.
                           8.1.12.1 Company overview
                           8.1.12.2 Financial performance
                           8.1.12.3 Product benchmarking
                           8.1.12.4 Strategic initiatives
                       8.1.13 WuXi Biologics
                           8.1.13.1 Company overview
                           8.1.13.2 Financial performance
                           8.1.13.3 Product benchmarking
                           8.1.13.4 Strategic initiatives
                       8.1.14 AbbVie, Inc.
                           8.1.14.1 Company overview
                           8.1.14.2 Financial performance
                           8.1.14.3 Product benchmarking
                           8.1.14.4 Strategic initiatives
                       8.1.15 Charles River Laboratories International, Inc
                           8.1.15.1 Company overview
                           8.1.15.2 Financial performance
                           8.1.15.3 Product benchmarking
                           8.1.15.4 Strategic initiatives
                       8.1.16 ICON plc.
                           8.1.16.1 Company overview
                           8.1.16.2 Financial performance
                           8.1.16.3 Product benchmarking
                           8.1.16.4 Strategic initiatives
                       8.1.17 Laboratory Corporation of America Holdings
                           8.1.17.1 Company overview
                           8.1.17.2 Financial performance
                           8.1.17.3 Product benchmarking
                           8.1.17.4 Strategic initiatives
                       8.1.18 Parexel International Corporation
                           8.1.18.1 Company overview
                           8.1.18.2 Financial performance
                           8.1.18.3 Product benchmarking
                           8.1.18.4 Strategic initiatives

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global biopharmaceutical CMO & CRO market, by source, 2018 - 2030 (USD Million)
Table 4 Global biopharmaceutical CMO & CRO market, by service type, 2018 - 2030 (USD Million)
Table 5 Global biopharmaceutical CMO & CRO market, by product, 2018 - 2030 (USD Million)
Table 6 Global biopharmaceutical CMO & CRO market, by region, 2018 - 2030 (USD Million)
Table 7 North America biopharmaceutical CMO & CRO market, by country, 2018 - 2030 (USD Million)
Table 8 North America biopharmaceutical CMO & CRO market, by source, 2018 - 2030 (USD Million)
Table 9 North America biopharmaceutical CMO & CRO market, by service type, 2018 - 2030 (USD Million)
Table 10 North America biopharmaceutical CMO & CRO market, by product, 2018 - 2030 (USD Million)
Table 11 U.S. biopharmaceutical CMO & CRO market, by source, 2018 - 2030 (USD Million)
Table 12 U.S. biopharmaceutical CMO & CRO market, by service type, 2018 - 2030 (USD Million)
Table 13 U.S. biopharmaceutical CMO & CRO market, by product, 2018 - 2030 (USD Million)
Table 14 Canada biopharmaceutical CMO & CRO market, by source, 2018 - 2030 (USD Million)
Table 15 Canada biopharmaceutical CMO & CRO market, by service type, 2018 - 2030 (USD Million)
Table 16 Canada biopharmaceutical CMO & CRO market, by product, 2018 - 2030 (USD Million)
Table 17 Europe biopharmaceutical CMO & CRO market, by country, 2018 - 2030 (USD Million)
Table 18 Europe biopharmaceutical CMO & CRO market, by source, 2018 - 2030 (USD Million)
Table 19 Europe biopharmaceutical CMO & CRO market, by service type, 2018 - 2030 (USD Million)
Table 20 Europe biopharmaceutical CMO & CRO market, by product, 2018 - 2030 (USD Million)
Table 21 Germany biopharmaceutical CMO & CRO market, by source, 2018 - 2030 (USD Million)
Table 22 Germany biopharmaceutical CMO & CRO market, by service type, 2018 - 2030 (USD Million)
Table 23 Germany biopharmaceutical CMO & CRO market, by product, 2018 - 2030 (USD Million)
Table 24 UK biopharmaceutical CMO & CRO market, by source, 2018 - 2030 (USD Million)
Table 25 UK biopharmaceutical CMO & CRO market, by service type, 2018 - 2030 (USD Million)
Table 26 UK biopharmaceutical CMO & CRO market, by product, 2018 - 2030 (USD Million)
Table 27 France biopharmaceutical CMO & CRO market, by source, 2018 - 2030 (USD Million)
Table 28 France biopharmaceutical CMO & CRO market, by service type, 2018 - 2030 (USD Million)
Table 29 France biopharmaceutical CMO & CRO market, by product, 2018 - 2030 (USD Million)
Table 30 Italy biopharmaceutical CMO & CRO market, by source, 2018 - 2030 (USD Million)
Table 31 Italy biopharmaceutical CMO & CRO market, by service type, 2018 - 2030 (USD Million)
Table 32 Italy biopharmaceutical CMO & CRO market, by product, 2018 - 2030 (USD Million)
Table 33 Spain biopharmaceutical CMO & CRO market, by source, 2018 - 2030 (USD Million)
Table 34 Spain biopharmaceutical CMO & CRO market, by service type, 2018 - 2030 (USD Million)
Table 35 Spain biopharmaceutical CMO & CRO market, by product, 2018 - 2030 (USD Million)
Table 36 Denmark biopharmaceutical CMO & CRO market, by source, 2018 - 2030 (USD Million)
Table 37 Denmark biopharmaceutical CMO & CRO market, by service type, 2018 - 2030 (USD Million)
Table 38 Denmark biopharmaceutical CMO & CRO market, by product, 2018 - 2030 (USD Million)
Table 39 Sweden biopharmaceutical CMO & CRO market, by source, 2018 - 2030 (USD Million)
Table 40 Sweden biopharmaceutical CMO & CRO market, by service type, 2018 - 2030 (USD Million)
Table 41 Sweden biopharmaceutical CMO & CRO market, by product, 2018 - 2030 (USD Million)
Table 42 Norway biopharmaceutical CMO & CRO market, by source, 2018 - 2030 (USD Million)
Table 43 Norway biopharmaceutical CMO & CRO market, by service type, 2018 - 2030 (USD Million)
Table 44 Norway biopharmaceutical CMO & CRO market, by product, 2018 - 2030 (USD Million)
Table 45 Asia Pacific biopharmaceutical CMO & CRO market, by country, 2018 - 2030 (USD Million)
Table 46 Asia Pacific biopharmaceutical CMO & CRO market, by source, 2018 - 2030 (USD Million)
Table 47 Asia Pacific biopharmaceutical CMO & CRO market, by service type, 2018 - 2030 (USD Million)
Table 48 Asia Pacific biopharmaceutical CMO & CRO market, by product, 2018 - 2030 (USD Million)
Table 49 Japan biopharmaceutical CMO & CRO market, by source, 2018 - 2030 (USD Million)
Table 50 Japan biopharmaceutical CMO & CRO market, by service type, 2018 - 2030 (USD Million)
Table 51 Japan biopharmaceutical CMO & CRO market, by product, 2018 - 2030 (USD Million)
Table 52 China biopharmaceutical CMO & CRO market, by source, 2018 - 2030 (USD Million)
Table 53 China biopharmaceutical CMO & CRO market, by service type, 2018 - 2030 (USD Million)
Table 54 China biopharmaceutical CMO & CRO market, by product, 2018 - 2030 (USD Million)
Table 55 India biopharmaceutical CMO & CRO market, by source, 2018 - 2030 (USD Million)
Table 56 India biopharmaceutical CMO & CRO market, by service type, 2018 - 2030 (USD Million)
Table 57 India biopharmaceutical CMO & CRO market, by product, 2018 - 2030 (USD Million)
Table 58 Australia biopharmaceutical CMO & CRO market, by source, 2018 - 2030 (USD Million)
Table 59 Australia biopharmaceutical CMO & CRO market, by service type, 2018 - 2030 (USD Million)
Table 60 Australia biopharmaceutical CMO & CRO market, by product, 2018 - 2030 (USD Million)
Table 61 South Korea biopharmaceutical CMO & CRO market, by source, 2018 - 2030 (USD Million)
Table 62 South Korea biopharmaceutical CMO & CRO market, by service type, 2018 - 2030 (USD Million)
Table 63 South Korea biopharmaceutical CMO & CRO market, by product, 2018 - 2030 (USD Million)
Table 64 Thailand biopharmaceutical CMO & CRO market, by source, 2018 - 2030 (USD Million)
Table 65 Thailand biopharmaceutical CMO & CRO market, by service type, 2018 - 2030 (USD Million)
Table 66 Thailand biopharmaceutical CMO & CRO market, by product, 2018 - 2030 (USD Million)
Table 67 Latin America biopharmaceutical CMO & CRO market, by country, 2018 - 2030 (USD Million)
Table 68 Latin America biopharmaceutical CMO & CRO market, by source, 2018 - 2030 (USD Million)
Table 69 Latin America biopharmaceutical CMO & CRO market, by service type, 2018 - 2030 (USD Million)
Table 70 Latin America biopharmaceutical CMO & CRO market, by product, 2018 - 2030 (USD Million)
Table 71 Brazil biopharmaceutical CMO & CRO market, by source, 2018 - 2030 (USD Million)
Table 72 Brazil biopharmaceutical CMO & CRO market, by service type, 2018 - 2030 (USD Million)
Table 73 Brazil biopharmaceutical CMO & CRO market, by product, 2018 - 2030 (USD Million)
Table 74 Mexico biopharmaceutical CMO & CRO market, by source, 2018 - 2030 (USD Million)
Table 75 Mexico biopharmaceutical CMO & CRO market, by service type, 2018 - 2030 (USD Million)
Table 76 Mexico biopharmaceutical CMO & CRO market, by product, 2018 - 2030 (USD Million)
Table 77 Argentina biopharmaceutical CMO & CRO market, by source, 2018 - 2030 (USD Million)
Table 78 Argentina biopharmaceutical CMO & CRO market, by service type, 2018 - 2030 (USD Million)
Table 79 Argentina biopharmaceutical CMO & CRO market, by product, 2018 - 2030 (USD Million)
Table 80 Colombia biopharmaceutical CMO & CRO market, by source, 2018 - 2030 (USD Million)
Table 81 Colombia biopharmaceutical CMO & CRO market, by service type, 2018 - 2030 (USD Million)
Table 82 Colombia biopharmaceutical CMO & CRO market, by product, 2018 - 2030 (USD Million)
Table 83 Middle East & Africa biopharmaceutical CMO & CRO market, by country, 2018 - 2030 (USD Million)
Table 84 Middle East & Africa biopharmaceutical CMO & CRO market, by source, 2018 - 2030 (USD Million)
Table 85 Middle East & Africa biopharmaceutical CMO & CRO market, by service type, 2018 - 2030 (USD Million)
Table 86 Middle East & Africa biopharmaceutical CMO & CRO market, by product, 2018 - 2030 (USD Million)
Table 87 South Africa biopharmaceutical CMO & CRO market, by source, 2018 - 2030 (USD Million)
Table 88 South Africa biopharmaceutical CMO & CRO market, by service type, 2018 - 2030 (USD Million)
Table 89 South Africa biopharmaceutical CMO & CRO market, by product, 2018 - 2030 (USD Million)
Table 90 Saudi Arabia biopharmaceutical CMO & CRO market, by source, 2018 - 2030 (USD Million)
Table 91 Saudi Arabia biopharmaceutical CMO & CRO market, by service type, 2018 - 2030 (USD Million)
Table 92 Saudi Arabia biopharmaceutical CMO & CRO market, by product, 2018 - 2030 (USD Million)
Table 93 UAE biopharmaceutical CMO & CRO market, by source, 2018 - 2030 (USD Million)
Table 94 UAE biopharmaceutical CMO & CRO market, by service type, 2018 - 2030 (USD Million)
Table 95 UAE biopharmaceutical CMO & CRO market, by product, 2018 - 2030 (USD Million)
Table 96 Kuwait biopharmaceutical CMO & CRO market, by source, 2018 - 2030 (USD Million)
Table 97 Kuwait biopharmaceutical CMO & CRO market, by service type, 2018 - 2030 (USD Million)
Table 98 Kuwait biopharmaceutical CMO & CRO market, by product, 2018 - 2030 (USD Million)
Table 99 2022 pipeline of biologics
Table 100 Some commercially available biopharmaceuticals and biologics produced using both mammalian & non-mammalian cell lines
Table 101 Some commercially available biopharmaceuticals and biologics produced using only mammalian cell lines
Table 102 Some biopharmaceuticals produced using S. cerevisiae
Table 103 Some commercially available biopharmaceuticals and biologics produced using only microbial cell lines
Table 104 Some commercially available monoclonal antibody products

List of Figures

Fig. 1 Market research process
Fig. 2 Information Procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain based sizing & forecasting
Fig. 6 QFD modelling for market share assessment
Fig. 7 Market segmentation & scope
Fig. 8 Biopharmaceutical CMO & CRO market outlook, 2018 - 2030
Fig. 9 Market trends & outlook
Fig. 10 Market driver relevance analysis (Current & future impact)
Fig. 11 Cumulative success rate comparison of biologics with small molecules over time
Fig. 12 Number of biologics investigational new drugs, 2005-2021
Fig. 13 Number of Reference Products by U.S. Biosimilars Launchable Dates
Fig. 14 Market restraint relevance analysis (Current & future impact)
Fig. 15 Risk associated with outsourcing services
Fig. 16 PEST Analysis (political & legal, economic and technological)
Fig. 17 Porter’s Five Forces Analysis
Fig. 18 Company market share analysis
Fig. 19 Strategy framework
Fig. 20 Participant categorization
Fig. 21 CMO selection process
Fig. 22 Trends in the biopharmaceutical industry
Fig. 23 R&D process of biopharmaceutical development
Fig. 24 Development phases where outsourcing partners are engaged
Fig. 25 Global biopharmaceuticals CMO & CRO market: Source outlook key takeaways
Fig. 26 Global Biopharmaceuticals CMO & CRO market: Source movement analysis
Fig. 27 Global mammalian source market, 2018 - 2030 (USD Million)
Fig. 28 Global mammalian source market, 2018 - 2030 (USD Million)
Fig. 29 Global biopharmaceuticals CMO & CRO market: Service type outlook key takeaways
Fig. 30 Global biopharmaceuticals CMO & CRO market: Service movement analysis
Fig. 31 Global contract manufacturing market, 2018 - 2030 (USD Million)
Fig. 32 Percentage of biomanufacturers outsourcing some activity of upstream and downstream processing, 2011-2016
Fig. 33 Global process development market, 2018 - 2030 (USD Million)
Fig. 34 Global downstream processing market, 2018 - 2030 (USD Million)
Fig. 35 Global upstream processing market, 2018 - 2030 (USD Million)
Fig. 36 Global fill & finish operations market, 2018 - 2030 (USD Million)
Fig. 37 Global analytical & QC testing market, 2018 - 2030 (USD Million)
Fig. 38 Global contract packaging market, 2018 - 2030 (USD Million)
Fig. 39 Breakdown of the general CRO industry by type of service
Fig. 40 Initial attributes that play key role into CRO engagement
Fig. 41 Post-engagement attributes that play key role into CRO engagement
Fig. 42 Global contract research market, 2018 - 2030 (USD Million)
Fig. 43 Global oncology market, 2018 - 2030 (USD Million)
Fig. 44 Global inflammation & immunology market, 2018 - 2030 (USD Million)
Fig. 45 Global cardiology market, 2018 - 2030 (USD Million)
Fig. 46 Global neuroscience market, 2018 - 2030 (USD Million)
Fig. 47 Global other CRO services market, 2018 - 2030 (USD Million)
Fig. 48 Global biopharmaceuticals CMO & CRO market: Product outlook key takeaways
Fig. 49 Global biopharmaceuticals CMO & CRO market: Product movement analysis
Fig. 50 Global biologics market, 2018 - 2030 (USD Million)
Fig. 51 Year wise annual approvals for MAbs products which are currently marketed in U.S./EU
Fig. 52 Share of MAbs-related R&D programs at different pipeline phases, 2015
Fig. 53 Global monoclonal antibodies market, 2018 - 2030 (USD Million)
Fig. 54 Comparison of R&D biotech pipeline expansion for recombinant products
Fig. 55 Global recombinant proteins market, 2018 - 2030 (USD Million)
Fig. 56 Global vaccines market, 2018 - 2030 (USD Million)
Fig. 57 Global antisense, RNAi, &molecular therapy market, 2018 - 2030 (USD Million)
Fig. 58 Global other product market, 2018 - 2030 (USD Million)
Fig. 59 Global biosimilars market, 2018 - 2030 (USD Million)
Fig. 60 Regional market place: Key takeaway
Fig. 61 Comparison of biopharmaceutical manufacturing facilities region and country wise
Fig. 62 Biopharmaceuticals CMO & CRO regional outlook, 2020 & 2028
Fig. 63 North America biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Million)
Fig. 64 Number of U.S. pharmaceutical outsourcing M&A transactions
Fig. 65 Biopharmaceuticals goods export growth comparison between 2011 and 2014
Fig. 66 U.S. biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Million)
Fig. 67 Pros and cons of Canadian pharmaceutical & biopharmaceutical industry
Fig. 68 Canada biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Million)
Fig. 69 Europe biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Million)
Fig. 70 Revenue growth of Germany pharmaceutical industry
Fig. 71 UK biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Million)
Fig. 72 Germany biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Million)
Fig. 73 France biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Million)
Fig. 74 Italy biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Million)
Fig. 75 Spain biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Million)
Fig. 76 Norway biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Million)
Fig. 77 Denmark biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Million)
Fig. 78 Sweden biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Million)
Fig. 77 Factors supporting contract manufacturing/research in Asian countries
Fig. 78 Asia Pacific biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Million)
Fig. 79 China biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Million)
Fig. 80 India biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Million)
Fig. 81 Japan biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Million)
Fig. 82 South Korea biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Million)
Fig. 83 Thailand biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Million)
Fig. 84 Australia biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Million)
Fig. 85 Latin America biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Million)
Fig. 86 Brazil biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Million)
Fig. 87 Mexico biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Million)
Fig. 88 Colombia biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Million)
Fig. 89 Argentina biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Million)
Fig. 90 Middle East & Africa biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Million)
Fig. 91 South Africa biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Million)
Fig. 92 Saudi Arabia biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Million)
Fig. 93 UAE biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Million)
Fig. 94 Kuwait biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Million)